Vitamin D3 for Life

Live Enlightened

Physiology

Early-Life Vitamin D and Childhood Immune Trajectories: Study Summary

Previous related pageEarly-Life Vitamin D and Childhood Immune Trajectories: Full Evidence ReviewNext related pageEarly-Life Vitamin D and Childhood Immune Trajectories: Full Evidence Review
Study at a glance

What was studied?

Does vitamin D in early life affect developing immune cells or later childhood illness? The review compares an animal experiment with five independent human research programmes.

What did the studies find?

A mouse study found changes in developing blood-forming cells and their descendants. Two pregnancy trials did not show a clear breathing-related benefit at six years from higher supplementation. A higher infant regimen did not reduce overall reported infections. Two observational programmes gave different results for vitamin D status and an immune response linked to type 1 diabetes.

What does this mean?

Experimental cell changes, childhood illnesses and disease-risk markers answer different questions. The evidence does not establish that higher supplementation improves every part of immune development or prevents childhood immune disease.

What are the limits?

The human studies did not directly measure normal immune maturation. An association with vitamin D status does not prove prevention. Animal results do not establish the same effect in children. Some supplementary material was unavailable.

Read the full article below ↓

Researchers ask whether vitamin D in early life affects developing immune cells or changes the risk of later illness. These are related questions, but they need different kinds of evidence. This summary compares an animal experiment with human studies of childhood breathing problems, infections and an immune response linked to type 1 diabetes. The findings do not establish that vitamin D determines a child’s future immune health. For the detailed evidence review, read Early-Life Vitamin D and Childhood Immune Trajectories: Full Evidence Review.

What evidence was examined?

The detailed review includes five independent human research programmes. COPSAC and VDAART tested vitamin D during pregnancy and followed children’s respiratory health. VIDI tested two vitamin D3 regimens during infancy. TEDDY and DAISY observed vitamin D status or intake and later immune-related outcomes.

These studies did not directly measure every stage of normal immune development. Vitamin D and Innate Responses: Recognition, Peptides and Function: Full Evidence Review explains why immune signals and defence functions need separate measurements. A separate mouse study by Oh and colleagues examined changes in developing blood-forming cells and their descendants. This supplies experimental evidence about developmental immune-cell programming, but it does not establish the same process in children.

What did the animal experiment show?

The mouse experiment compared cells from offspring exposed to different maternal vitamin D conditions. The cell preparations contained stem cells and other early blood-forming cells. Their descendants included macrophages, immune cells that also act within body tissues.

After transfers into adult mice, the researchers observed differences in macrophage behaviour and metabolic outcomes. This supports a developmental effect under those experimental conditions. However, the original cell populations differed in their composition. The result cannot be assigned confidently to a change in one identical cell type.

The study also examined cells from 30 human cord-blood samples. It did not follow those children to establish later immune development or disease. The findings do not prove permanent damage, or that supplementation prevents childhood diabetes. Vitamin D and Lasting Gene Regulation: Full Evidence Review explores what evidence is needed to establish a lasting biological response.

Did pregnancy supplementation prevent breathing problems?

The six-year COPSAC follow-up recorded asthma in 23 of 274 children in the higher-dose group and 18 of 268 in the comparison group. This did not establish a preventive benefit. The uncertainty was wide enough that the result also cannot prove harm or exact equality between the regimens.

VDAART followed children whose parents had a history of allergic disease. By six years, asthma or repeated wheezing occurred in 176 of 405 children in the higher-dose group and 184 of 401 in the comparison group. The main analysis did not show a clear difference.

These trials tested pregnancy regimens, not every possible timing or childhood intervention. Their six-year reports are follow-ups of the original trials, not new independent trials. The VDAART appendix was unavailable for this review, so detailed supplementary claims were not assessed.

Did a higher infant dose reduce infections?

VIDI compared two vitamin D3 regimens from about two weeks to two years of age in Finland. The infants were healthy and born at term, meaning they were not born prematurely, and almost all had sufficient vitamin D at birth by the study’s definition.

The higher regimen increased vitamin D blood levels but did not reduce the overall rate of reported infections. Parents recorded the illnesses, so these were not all laboratory-confirmed infections. The findings should not be assumed to describe severely deficient infants or infants born early.

This result separates a blood measurement from a health outcome. Vitamin D Testing: 25-OH-D vs 1,25-OH₂-D explains the different blood markers used in vitamin D research. Raising the measured vitamin D level did not necessarily improve the outcome being studied. Infection counts also do not describe every part of immune development.

What about immune changes linked to diabetes?

TEDDY and DAISY studied children at increased risk of type 1 diabetes. They examined islet autoimmunity: an immune response against insulin-producing tissue in the pancreas. This is not the same as a diagnosis of diabetes.

TEDDY found that higher measured vitamin D status was associated with lower odds of this immune response. Its first infant samples were taken at three, six or nine months, not at birth. The association does not prove that raising a child’s blood level prevents disease.

DAISY did not find a clear association between measured vitamin D status and these outcomes. The studies differed in their measurements and precision. Their disagreement means the observational evidence should not be presented as settled. DAISY’s missing-sample supplement was not available, limiting assessment of that issue.

What can families take from this evidence?

Experimental developmental changes, illness counts and disease-risk markers should remain separate. The animal study supports a specific developmental phenomenon. The human studies do not establish a general benefit from higher supplementation or a blood target that prevents immune disease.

For current UK guidance, see NHS Vitamins for children. Infants born early need advice from their neonatal team.

Scientific sources

Oh J and colleagues. Embryonic vitamin D deficiency programs hematopoietic stem cells to induce type 2 diabetes. Nature Communications. 2023;14:3278. DOI: 10.1038/s41467-023-38849-z.

Brustad N and colleagues. High-Dose Vitamin D Supplementation During Pregnancy and Asthma in Offspring at the Age of 6 Years. JAMA. 2019;321:1003 to 1005. DOI: 10.1001/jama.2019.0052.

Litonjua AA and colleagues. Six-Year Follow-up of a Trial of Antenatal Vitamin D for Asthma Reduction. New England Journal of Medicine. 2020;382:525 to 533. DOI: 10.1056/NEJMoa1906137. Principal report assessed; appendix unavailable.

Rosendahl J and colleagues. Effect of Higher vs Standard Dosage of Vitamin D3 Supplementation on Bone Strength and Infection in Healthy Infants: A Randomized Clinical Trial. JAMA Pediatrics. 2018;172:646 to 654. DOI: 10.1001/jamapediatrics.2018.0602.

Norris JM and colleagues. Plasma 25-Hydroxyvitamin D Concentration and Risk of Islet Autoimmunity. Diabetes. 2018;67:146 to 154. DOI: 10.2337/db17-0802.

Simpson M and colleagues. No association of vitamin D intake or 25-hydroxyvitamin D levels in childhood with risk of islet autoimmunity and type 1 diabetes: the Diabetes Autoimmunity Study in the Young (DAISY). Diabetologia. 2011;54:2779 to 2788. DOI: 10.1007/s00125-011-2278-2. Principal report assessed; missing-sample supplement unavailable.

Related reading

Original sources

Source

Vitamins for children

For current UK guidance, see NHS Vitamins for children.

Publication details

For current UK guidance, see NHS Vitamins for children. Infants born early need advice from their neonatal team.

Read more →
Source

No association of vitamin D intake or 25-hydroxyvitamin D levels in childhood with risk of islet autoimmunity and type 1 diabetes: the Diabetes Autoimmunity Study in the Young (DAISY)

Published in Diabetologia (2011).

Publication details

Simpson M and colleagues. No association of vitamin D intake or 25-hydroxyvitamin D levels in childhood with risk of islet autoimmunity and type 1 diabetes: the Diabetes Autoimmunity Study in the Young (DAISY). Diabetologia. 2011;54:2779 to 2788. DOI: 10.1007/s00125-011-2278-2. Principal report assessed; missing-sample supplement unavailable.

Read more →